Literature DB >> 26208438

Small-Scale Assays for Studying Dissolution of Pharmaceutical Cocrystals for Oral Administration.

Karl J Box1, John Comer1, Robert Taylor1, Shyam Karki2, Rebeca Ruiz1, Robert Price3, Nikoletta Fotaki4.   

Abstract

The purpose of this study was to better understand the dissolution properties and precipitation behavior of pharmaceutical cocrystals of poorly soluble drugs for the potential for oral administration based on a small-scale dissolution assay. Carbamazepine and indomethacin cocrystals with saccharin and nicotinamide as coformers were prepared with the sonic slurry method. Dissolution of the poorly soluble drugs indomethacin and carbamazepine and their cocrystals was studied with a small-scale dissolution assay installed on a SiriusT3 instrument. Two methodologies were used: (i) surface dissolution of pressed tablet (3 mm) in 20 mL running for fixed times at four pH stages (pH 1.8, pH 3.9, pH 5.4, pH 7.3) and (ii) powder dissolution (2.6 mg) in 2 mL at a constant pH (pH 2). Improved dissolution and useful insights into precipitation kinetics of poorly soluble compounds from the cocrystal form can be revealed by the small-scale dissolution assay. A clear difference in dissolution/precipitation behaviour can be observed based on the characteristics of the coformer used.

Entities:  

Keywords:  carbamazepine; cocrystal; indomethacin; precipitation; small-scale dissolution

Mesh:

Substances:

Year:  2015        PMID: 26208438      PMCID: PMC4984899          DOI: 10.1208/s12249-015-0362-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  21 in total

Review 1.  Solution-mediated phase transformation: significance during dissolution and implications for bioavailability.

Authors:  Kristyn Greco; Robin Bogner
Journal:  J Pharm Sci       Date:  2011-12-27       Impact factor: 3.534

Review 2.  Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

Authors:  N Blagden; M de Matas; P T Gavan; P York
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

Review 3.  Pharmaceutical co-crystals-an opportunity for drug product enhancement.

Authors:  Inna Miroshnyk; Sabiruddin Mirza; Niklas Sandler
Journal:  Expert Opin Drug Deliv       Date:  2009-04       Impact factor: 6.648

Review 4.  Pharmaceutical cocrystals and poorly soluble drugs.

Authors:  Ranjit Thakuria; Amit Delori; William Jones; Maya P Lipert; Lilly Roy; Naír Rodríguez-Hornedo
Journal:  Int J Pharm       Date:  2012-12-01       Impact factor: 5.875

5.  Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.

Authors:  Daniel P McNamara; Scott L Childs; Jennifer Giordano; Anthony Iarriccio; James Cassidy; Manjunath S Shet; Richard Mannion; Ed O'Donnell; Aeri Park
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

6.  Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.

Authors:  Julius F Remenar; Sherry L Morissette; Matthew L Peterson; Brian Moulton; J Michael MacPhee; Héctor R Guzmán; Orn Almarsson
Journal:  J Am Chem Soc       Date:  2003-07-16       Impact factor: 15.419

7.  Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids.

Authors:  Scott L Childs; Leonard J Chyall; Jeanette T Dunlap; Valeriya N Smolenskaya; Barbara C Stahly; G Patrick Stahly
Journal:  J Am Chem Soc       Date:  2004-10-20       Impact factor: 15.419

8.  Simultaneous UV imaging and raman spectroscopy for the measurement of solvent-mediated phase transformations during dissolution testing.

Authors:  Jesper Østergaard; Jian X Wu; Kaisa Naelapää; Johan P Boetker; Henrik Jensen; Jukka Rantanen
Journal:  J Pharm Sci       Date:  2014-02-04       Impact factor: 3.534

9.  Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds.

Authors:  Koji Shiraki; Noriyuki Takata; Ryusuke Takano; Yoshiki Hayashi; Katsuhide Terada
Journal:  Pharm Res       Date:  2008-07-24       Impact factor: 4.200

Review 10.  Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.

Authors:  David P Elder; René Holm; Heidi Lopez de Diego
Journal:  Int J Pharm       Date:  2012-11-24       Impact factor: 5.875

View more
  4 in total

1.  Cocrystal Solubility Product Prediction Using an in combo Model and Simulations to Improve Design of Experiments.

Authors:  Alex Avdeef
Journal:  Pharm Res       Date:  2018-02-02       Impact factor: 4.200

2.  Superior Solubility and Dissolution of Zaltoprofen via Pharmaceutical Cocrystals.

Authors:  Prabhakar Panzade; Giridhar Shendarkar
Journal:  Turk J Pharm Sci       Date:  2019-07-10

3.  Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.

Authors:  Prabhakar Panzade; Giridhar Shendarkar; Sarfaraj Shaikh; Pavan Balmukund Rathi
Journal:  Adv Pharm Bull       Date:  2017-09-25

4.  Crystal Structure, Solubility, and Pharmacokinetic Study on a Hesperetin Cocrystal with Piperine as Coformer.

Authors:  Yanjie Liu; Fan Yang; Xiuhua Zhao; Siying Wang; Qilei Yang; Xiaoxue Zhang
Journal:  Pharmaceutics       Date:  2022-01-01       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.